Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat alpha Synuclein ELISA Kit (AC2722)
Cat.#: ASET-1311
Specifications
Description Rat alpha Synuclein ELISA Kit allows for the in vitro quantitative determination of rat alpha Synuclein concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1017 Mouse Iba1 ELISA Kit (AC2428) Quantitative inquiry ASET-2431 Estradiol ELISA Kit (AC3842) Quantitative inquiry ASET-1629 Mouse Ephrin A1 ELISA Kit (AC3040) Quantitative inquiry ASET-1261 Rat AKR7A2 ELISA Kit (AC2672) Quantitative inquiry ASET-1522 Human P Cadherin ELISA Kit (AC2933) Quantitative inquiry ASET-1195 Human Kallikrein 6 ELISA Kit (AC2606) Quantitative inquiry ASET-2458 Human Meteorin ELISA Kit (AC3869) Quantitative inquiry ASET-1972 Human Progranulin ELISA Kit (AC3383) Quantitative inquiry ASET-2149 Human SOX10 ELISA Kit (AC3560) Quantitative inquiry ASET-1302 Mouse Laminin alpha 1 ELISA Kit (AC2713) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket